RPRX
Royalty Pharma plcNASDAQStock$63.47+1.32 (+2.12%)Mkt Cap 28.3BP/E 35.14Div Yield 1.49%Beta 0.41Vol 1.3MAvg Vol 3.2M
52W$36.41
$63.96
ETFs That Hold RPRX (Royalty Pharma plc)
1M
+8.46%
3M
+7.89%
6M
+27.83%
YTD
+63.33%
1Y
+72.29%
3Y
+131.81%
5Y
+68.49%
ETFs That Hold RPRX
Royalty Pharma plc is held by 207 ETFs. The largest position by market value is in VFLO (VictoryShares Free Cash Flow ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.02% |
| SPUT | Innovator Equity Premium Income – Daily PutWrite ETF | 0.02% |
| AVUC | Avantis U.S. Core Equity ETF | 0.00% |
| GXLC | Global X - U.S. 500 ETF | 0.04% |
| MHIP | Milliman Healthcare Inflation Plus ETF | 0.04% |
| MHIG | Milliman Healthcare Inflation Guard ETF | 0.02% |
| CPI | IQ Real Return ETF | 0.01% |
Excludes leveraged and inverse ETFs.
PreviousPage 11 of 11
Frequently Asked Questions
How many ETFs hold RPRX?
Royalty Pharma plc (RPRX) is held by 207 ETFs (excluding leveraged and inverse funds). The largest position by market value is in VFLO (VictoryShares Free Cash Flow ETF).
What is the largest ETF that holds RPRX?
By fund size, VFLO (VictoryShares Free Cash Flow ETF) with $11.84B in AUM holds 1.64% of its portfolio in RPRX, representing $194.8M in market value.
What percentage of PBE is RPRX?
RPRX makes up 4.80% of PBE (Invesco Biotechnology & Genome ETF), making it one of the largest positions in that fund.
Is RPRX in the S&P 500?
RPRX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.